GlassScriptPhysician profile
Matthew Scott Rossen
NPI 1306122205
$6,479.32
in general payments reported to CMS, 2019-2025
12 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,505 · 2020: $344 · 2021: $239 · 2022: $342 · 2023: $48.85 · 2024: $806 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429 · Travel and Lodging: $421 · Education: $150 · Entertainment: $48.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.81 |
| Travel and Lodging | $421.07 |
| Education | $150.00 |
| Entertainment | $48.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carestream Dental, LLC | $4,484.66 | 2019 | |
| Straumann USA LLC | $535.19 | 2021-2025 | |
| Stryker Corporation | $421.07 | 2024 | Physio - Lucas, Physio - Lifenet, Power-Pro |
| Zimmer Biomet Holdings, INC. | $186.57 | 2020 | |
| Benco Dental Supply Co. | $171.03 | 2021-2022 | |
| Keystone Dental INC. | $162.43 | 2022-2023 | |
| Implant Direct Sybron International LLC | $157.17 | 2020 | |
| Biohorizons Implant Systems INC. | $110.25 | 2024 | Biohorizons |
| Incyte Corporation | $109.99 | 2022 | |
| Lilly USA, LLC | $108.00 | 2025 | Zepbound |
| Eagle Pharmaceuticals, INC. | $20.77 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Rossen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.